Codex Genetics Partners with C2N Diagnostics to Introduce the PrecivityAD2™ Blood Test in Hong Kong, Facilitating Access to Innovative Alzheimer’s Disease Diagnostics

2026-03-10 - 02:37

HONG KONG, March 10, 2026 /PRNewswire/ — Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a global leader in in advanced brain health diagnostics. The partnership will introduce the PrecivityAD2TM blood test to healthcare professionals across Hong Kong, enabling access to C2N’s innovative